229 related articles for article (PubMed ID: 25832928)
21. Overdiagnosis of gastro-esophageal reflux disease and underdiagnosis of functional dyspepsia in a USA community.
Pleyer C; Bittner H; Locke GR; Choung RS; Zinsmeister AR; Schleck CD; Herrick LM; Talley NJ
Neurogastroenterol Motil; 2014 Aug; 26(8):1163-71. PubMed ID: 24916517
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of gastroesophageal reflux disease symptoms and uninvestigated dyspepsia in Korea: a population-based study.
Yang SY; Lee OY; Bak YT; Jun DW; Lee SP; Lee SH; Park GT; Yoon BC; Choi HS; Hahm JS; Lee MH; Lee DH
Dig Dis Sci; 2008 Jan; 53(1):188-93. PubMed ID: 17510800
[TBL] [Abstract][Full Text] [Related]
23. Assessing the impact of lifestyle modification education on knowledge and behavior changes in gastroesophageal reflux disease patients on proton pump inhibitors.
Finley K; Giannamore M; Bennett M; Hall L
J Am Pharm Assoc (2003); 2009; 49(4):544-8. PubMed ID: 19589767
[TBL] [Abstract][Full Text] [Related]
24. [Therapy of gastroesophageal reflux disease (GERD)].
Storr M
Med Monatsschr Pharm; 2011 Dec; 34(12):446-54; quiz 455-6. PubMed ID: 22233024
[TBL] [Abstract][Full Text] [Related]
25. Risk factors associated with gastroesophageal reflux disease relapse in primary care patients successfully treated with a proton pump inhibitor.
López-Colombo A; Pacio-Quiterio MS; Jesús-Mejenes LY; Rodríguez-Aguilar JE; López-Guevara M; Montiel-Jarquín AJ; López-Alvarenga JC; Morales-Hernández ER; Ortiz-Juárez VR; Ávila-Jiménez L
Rev Gastroenterol Mex; 2017; 82(2):106-114. PubMed ID: 28283313
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study.
Lee SY; Lee KJ; Kim SJ; Cho SW
Digestion; 2009; 79(3):196-201. PubMed ID: 19342860
[TBL] [Abstract][Full Text] [Related]
27. Overlap of symptoms of dyspepsia and gastroesophageal reflux in the community.
Kitapçioğlu G; Mandiracioğlu A; Caymaz Bor C; Bor S
Turk J Gastroenterol; 2007 Mar; 18(1):14-9. PubMed ID: 17450489
[TBL] [Abstract][Full Text] [Related]
28. Randomized study of lafutidine vs lansoprazole in patients with mild gastroesophageal reflux disease.
Takenaka R; Okada H; Kawano S; Komazawa Y; Yoshinaga F; Nagata S; Inoue M; Komatsu H; Onogawa S; Kushiyama Y; Mukai S; Todo H; Okanobu H; Manabe N; Tanaka S; Haruma K; Kinoshita Y
World J Gastroenterol; 2016 Jun; 22(23):5430-5. PubMed ID: 27340360
[TBL] [Abstract][Full Text] [Related]
29. [Update on current care guidelines. A current care guideline: recurrent upper gastrointestinal symptoms].
Paikka N
Duodecim; 2012; 128(22):2376-7. PubMed ID: 23342484
[TBL] [Abstract][Full Text] [Related]
30. Structured diagnostic and treatment approach versus the usual primary care approach in patients with gastroesophageal reflux disease: a cluster-randomized multicenter study.
Bergquist H; Agréus L; Tillander L; Johnsson F; Sörngård H; Sjöstedt S; Hellström PM
J Clin Gastroenterol; 2013 Aug; 47(7):e65-73. PubMed ID: 23426452
[TBL] [Abstract][Full Text] [Related]
31. [Study on lifestyle in patients with gastroesophageal
reflux disease].
Yuan L; Tang D; Peng J; Qu N; Yue C; Wang F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 May; 42(5):558-564. PubMed ID: 28626103
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of uninvestigated dyspepsia and gastroesophageal reflux disease in Korea: a population-based study using the Rome III criteria.
Min BH; Huh KC; Jung HK; Yoon YH; Choi KD; Song KH; Keum B; Kim JW;
Dig Dis Sci; 2014 Nov; 59(11):2721-9. PubMed ID: 24925147
[TBL] [Abstract][Full Text] [Related]
33. Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease.
Mönnikes H; Schwan T; van Rensburg C; Straszak A; Theek C; Sander P; Lühmann R
Aliment Pharmacol Ther; 2012 Jun; 35(11):1279-89. PubMed ID: 22486552
[TBL] [Abstract][Full Text] [Related]
34. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms.
Voutilainen M; Sipponen P; Mecklin JP; Juhola M; Färkkilä M
Digestion; 2000; 61(1):6-13. PubMed ID: 10671769
[TBL] [Abstract][Full Text] [Related]
35. Insights into gastroesophageal reflux disease-associated dyspeptic symptoms.
Gerson LB; Kahrilas PJ; Fass R
Clin Gastroenterol Hepatol; 2011 Oct; 9(10):824-33. PubMed ID: 21699806
[TBL] [Abstract][Full Text] [Related]
36. Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease.
Bytzer P; Jones R; Vakil N; Junghard O; Lind T; Wernersson B; Dent J
Clin Gastroenterol Hepatol; 2012 Dec; 10(12):1360-6. PubMed ID: 22813439
[TBL] [Abstract][Full Text] [Related]
37. Management of gastroesophageal reflux disease in primary care: results of a survey in 2 areas in Germany.
Meining A; Driesnack U; Classen M; Rösch T
Z Gastroenterol; 2002 Jan; 40(1):15-20. PubMed ID: 11803496
[TBL] [Abstract][Full Text] [Related]
38. The Prevalence and Clinical Features of Non-responsive Gastroesophageal Reflux Disease to Practical Proton Pump Inhibitor Dose in Korea: A Multicenter Study.
Park HJ; Park SH; Shim KN; Kim YS; Kim HJ; Han JP; Kim YS; Bang BW; Kim GH; Baik GH; Kim HH; Park SY; Kim SS
Korean J Gastroenterol; 2016 Jul; 68(1):16-22. PubMed ID: 27443619
[TBL] [Abstract][Full Text] [Related]
39. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
Peura DA; Kovacs TO; Metz DC; Siepman N; Pilmer BL; Talley NJ
Am J Med; 2004 Jun; 116(11):740-8. PubMed ID: 15144910
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy?
Takeuchi T; Oota K; Harada S; Edogawa S; Kojima Y; Sanomura M; Sakaguchi M; Hayashi K; Hongoh Y; Itabashi T; Kitae H; Hoshimoto M; Takeuchi N; Higuchi K
Intern Med; 2015; 54(2):97-105. PubMed ID: 25742999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
